Abstract
We present preliminary results of a case-control study to estimate influenza vaccine effectiveness in Spain, from week 50 of 2010 to week 6 of 2011. The adjusted effectiveness of the vaccine in preventing laboratory-confirmed influenza due to any type of influenza virus was 50% (95% CI: -6 to 77%) for the trivalent seasonal vaccine and 72% (95% CI: 7 to 92%) for both trivalent seasonal and monovalent pandemic vaccines, suggesting a protective effect of seasonal vaccination lower than that reported for the previous season.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Case-Control Studies
-
Child
-
Child, Preschool
-
Disease Outbreaks / prevention & control*
-
Female
-
Humans
-
Infant
-
Infant, Newborn
-
Influenza A Virus, H1N1 Subtype / immunology*
-
Influenza A Virus, H1N1 Subtype / isolation & purification
-
Influenza A Virus, H3N2 Subtype / isolation & purification
-
Influenza B virus / isolation & purification
-
Influenza Vaccines / administration & dosage*
-
Influenza Vaccines / immunology
-
Influenza, Human / diagnosis
-
Influenza, Human / epidemiology*
-
Influenza, Human / prevention & control*
-
Influenza, Human / virology
-
Logistic Models
-
Male
-
Middle Aged
-
Population Surveillance
-
Seasons
-
Spain / epidemiology
-
Treatment Outcome
-
Young Adult